CARDIOVASCULAR JOURNAL OF AFRICA • Volume 34, No 3, July/August 2023 AFRICA 187 29. Reers S, Karanatsios G, Borowski M, et al. Frequency of atrial thrombus formation in patients with atrial fibrillation under treatment with nonvitamin K oral anticoagulants in comparison to vitamin K antagonists: a systematic review and meta-analysis. Eur J Med Res 2018; 23: 49. 30. Frenkel D, D’Amato SA, Al-Kazaz M, et al. Prevalence of left atrial thrombus detection by transesophageal echocardiography: a comparison of continuous non-vitamin K antagonist oral anticoagulant versus warfarin therapy in patients undergoing catheter ablation for atrial fibrillation. J Am Coll Cardiol Clin Electrophysiol 2016; 2: 295–303. 31. Hwang J, Park HS, Jun SW, et al. The incidence of left atrial appendage thrombi on transesophageal echocardiography after pretreatment with apixaban for cardioversion in the real-world practice. PLoS One 2018; 13: e0208734. 32. Kawabata M, Goya M, Sasaki T, et al. Left atrial appendage thrombi formation in japanese non-valvular atrial fibrillation patients during anticoagulation therapy – warfarin vs. direct oral anticoagulants. Circ J 2017; 81: 645–651. 33. Uz O, Atalay M, Dogan M, et al. The CHA2DS2-VASc score as a predictor of left atrial thrombus in patients with non-valvular atrial fibrillation. Med Princ Pract 2014; 23: 234–238. 34. Tang RB, Dong JZ, Liu XP, et al. Is CHA2DS2-VASc score a predictor of left atrial thrombus in patients with paroxysmal atrial fibrillation? Thromb Haemost 2011; 105: 1107–1109. 35. Yarmohammadi H, Varr BC, Puwanant S, et al. Role of CHADS2 score in evaluation of thromboembolic risk and mortality in patients with atrial fibrillation undergoing direct current cardioversion (from the ACUTE Trial substudy). Am J Cardiol 2012; 110: 222–226. 36. Providencia R, Ferreira MJ, Goncalves L, et al. Mean corpuscular volume and red cell distribution width as predictors of left atrial stasis in patients with non-valvular atrial fibrillation. Am J Cardiovasc Dis 2013; 3: 91–102. 37. Providencia R, Faustino A, Paiva L, et al. Mean platelet volume is associated with the presence of left atrial stasis in patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord 2013; 13: 40. 38. Kecoglu S, Demir M, Uyan U, Melek M. The effects of eosinophil on the left atrial thrombus in patients with atrial fibrillation. Clin Appl Thromb Hemost 2014; 20: 285–289. 39. Tang RB, Dong JZ, Yan XL, et al. Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation. Can J Cardiol 2014; 30: 1415–1421. 40. Ochiumi Y, Kagawa E, Kato M, et al. Usefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation. J Arrhythm 2015; 31: 307–312. 41. Puwanant S, Varr BC, Shrestha K, et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol 2009; 54: 2032–2039. 42. Scherr D, Dalal D, Chilukuri K, et al. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2009; 20: 379–384. 43. Wallace TW, Atwater BD, Daubert JP, et al. Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter-directed atrial fibrillation ablation. J Cardiovasc Electrophysiol 2010; 21: 849–852. 44. Calvo N, Mont L, Vidal B, et al. Usefulness of transoesophageal echocardiography before circumferential pulmonary vein ablation in patients with atrial fibrillation: is it really mandatory? Europace 2011; 13: 486–491. 45. Zoppo F, Brandolino G, Berton A, et al. Predictors of left atrium appendage clot detection despite on-target warfarin prevention for atrial fibrillation. J Interv Card Electrophysiol 2012; 35: 151–158. 46. McCready JW, Nunn L, Lambiase PD, et al. Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory? Europace 2010; 12: 927–932. 47. Tsai LM, Lin LJ, Teng JK, Chen JH. Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation. Int J Cardiol 1997; 58: 163–169. 48. Watanabe A, Yamashita N, Yamashita T. Blood stasis secondary to heart failure forms warfarin-resistant left atrial thrombus. Int Heart J 2014; 55: 506–511. 49. Kleemann T, Becker T, Strauss M, et al. Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score. Eur J Echocardiogr 2009; 10: 383–388. 50. Zhao Y, Ji L, Liu J, et al. Intensity of left atrial spontaneous echo contrast as a correlate for stroke risk stratification in patients with nonvalvular atrial fibrillation. Sci Rep 2016; 6: 27650. 51. Ayirala S, Kumar S, O’Sullivan DM, Silverman DI. Echocardiographic predictors of left atrial appendage thrombus formation. J Am Soc Echocardiogr 2011; 24: 499–505. 52. Beigel R, Wunderlich NC, Ho SY, et al. The left atrial appendage: anatomy, function, and noninvasive evaluation. Cardiovasc Imaging 2014; 7: 1251–1265. 53. Veinot JP, Harrity PJ, Gentile F, et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation 1997; 96: 3112–3115. 54. Yamamoto M, Seo Y, Kawamatsu N, Sato K, et al. Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation. Circ Cardiovasc Imaging 2014; 7: 337–343. 55. Zhao Y, Zhang PP, Xu QF, et al. Relationship between left atrial appendage morphology and thrombus formation in patients with atrial fibrillation. Int J Cardiol 2015; 188: 86–88. 56. Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? J Am Coll Cardiol 2012; 60: 531–538. 57. Fukushima K, Fukushima N, Kato K, et al. Correlation between left atrial appendage morphology and flow velocity in patients with paroxysmal atrial fibrillation. Eur Heart J Cardiovasc Imaging 2016; 17: 59–66. 58. Kishima H, Mine T, Ashida K, et al. Does left atrial appendage morphology influence left atrial appendage flow velocity? Circ J 2015; 79: 1706–1711. 59. Uretsky S, Shah A, Bangalore S, et al. Assessment of left atrial appendage function with transthoracic tissue Doppler echocardiography. Eur J Echocardiogr 2009; 10: 363–371. 60. Goldman ME, Pearce LA, Hart RG, et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (the Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr 1999; 12: 1080–1087. 61. Farkowski MM, Jubele K, Marin F, et al. Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: results of the European Heart Rhythm Association survey. Europace 2020; 22: 162–169. 62. Steffel J, Collins R, Antz M, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace 2021, Apr 25; euab065. 63. Seidl K, Rameken M, Drogemuller A, et al. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study. J Am Coll Cardiol 2002; 39:1436–1442.
RkJQdWJsaXNoZXIy NDIzNzc=